United Capital Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.84M | Buy |
13,122
+1,156
| +10% | +$515K | 0.05% | 258 |
|
|
2025
Q1 | $5.8M | Buy |
11,966
+602
| +5% | +$292K | 0.05% | 252 |
|
|
2024
Q4 | $4.58M | Sell |
11,364
-21
| -0.2% | -$8.46K | 0.04% | 270 |
|
|
2024
Q3 | $5.29M | Buy |
11,385
+1,013
| +10% | +$471K | 0.04% | 253 |
|
|
2024
Q2 | $4.86M | Buy |
10,372
+151
| +1% | +$70.8K | 0.04% | 264 |
|
|
2024
Q1 | $4.27M | Buy |
10,221
+199
| +2% | +$83.2K | 0.04% | 304 |
|
|
2023
Q4 | $4.08M | Buy |
10,022
+1,437
| +17% | +$585K | 0.03% | 314 |
|
|
2023
Q3 | $2.99M | Sell |
8,585
-185
| -2% | -$64.3K | 0.02% | 371 |
|
|
2023
Q2 | $3.09M | Sell |
8,770
-152
| -2% | -$53.5K | 0.02% | 380 |
|
|
2023
Q1 | $2.81M | Sell |
8,922
-998
| -10% | -$314K | 0.02% | 396 |
|
|
2022
Q4 | $2.86M | Sell |
9,920
-211
| -2% | -$60.9K | 0.02% | 416 |
|
|
2022
Q3 | $2.93M | Buy |
10,131
+5,446
| +116% | +$1.58M | 0.02% | 411 |
|
|
2022
Q2 | $1.32M | Buy |
4,685
+3,439
| +276% | +$969K | 0.01% | 579 |
|
|
2022
Q1 | $325K | Sell |
1,246
-256
| -17% | -$66.8K | ﹤0.01% | 960 |
|
|
2021
Q4 | $330K | Buy |
1,502
+48
| +3% | +$10.5K | ﹤0.01% | 997 |
|
|
2021
Q3 | $264K | Sell |
1,454
-570
| -28% | -$103K | ﹤0.01% | 1050 |
|
|
2021
Q2 | $408K | Sell |
2,024
-371
| -15% | -$74.8K | ﹤0.01% | 919 |
|
|
2021
Q1 | $515K | Sell |
2,395
-640
| -21% | -$138K | ﹤0.01% | 840 |
|
|
2020
Q4 | $717K | Sell |
3,035
-21,264
| -88% | -$5.02M | ﹤0.01% | 755 |
|
|
2020
Q3 | $6.61M | Sell |
24,299
-98
| -0.4% | -$26.7K | 0.04% | 294 |
|
|
2020
Q2 | $7.08M | Buy |
24,397
+3,846
| +19% | +$1.12M | 0.05% | 301 |
|
|
2020
Q1 | $4.89M | Sell |
20,551
-2,853
| -12% | -$679K | 0.04% | 344 |
|
|
2019
Q4 | $5.12M | Buy |
23,404
+384
| +2% | +$84.1K | 0.03% | 415 |
|
|
2019
Q3 | $3.9M | Buy |
23,020
+795
| +4% | +$135K | 0.03% | 467 |
|
|
2019
Q2 | $4.08M | Buy |
22,225
+2,653
| +14% | +$487K | 0.03% | 456 |
|
|
2019
Q1 | $3.6M | Buy |
19,572
+2,435
| +14% | +$448K | 0.03% | 468 |
|
|
2018
Q4 | $2.84M | Buy |
17,137
+2,449
| +17% | +$406K | 0.02% | 484 |
|
|
2018
Q3 | $2.83M | Buy |
14,688
+2,949
| +25% | +$568K | 0.02% | 540 |
|
|
2018
Q2 | $2M | Buy |
11,739
+2,495
| +27% | +$424K | 0.01% | 593 |
|
|
2018
Q1 | $1.51M | Sell |
9,244
-3,586
| -28% | -$585K | 0.01% | 660 |
|
|
2017
Q4 | $1.92M | Buy |
12,830
+1,101
| +9% | +$165K | 0.02% | 598 |
|
|
2017
Q3 | $1.78M | Buy |
11,729
+6,633
| +130% | +$1.01M | 0.02% | 612 |
|
|
2017
Q2 | $657K | Buy |
+5,096
| New | +$657K | 0.01% | 866 |
|